Cost-utility analysis of timolol versus latanoprost versus travoprost in the treatment of glaucoma and ocular hypertension

被引：0
|
作者：
Lilliu, H
Le Pen, C
Berdeaux, G
机构：
[1] Alcon Labs Inc, Rueil Malmaison, France
[2] Clp Sante, Paris, France
来源：
VALUE IN HEALTH | 2002年 / 5卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)61457-X
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：552 / 553
页数：2
相关论文
共 50 条
  • [21] SAFETY PROFILE OF LATANOPROST VERSUS TIMOLOL IN PATIENTS WITH OPEN ANGLE GLAUCOMA OR OCULAR HYPERTENSION: POST 2000 SETTING
    Gupta, J.
    Siddiqui, M. K.
    Jindal, R.
    Sehgal, M.
    VALUE IN HEALTH, 2011, 14 (03) : A54 - A54
  • [22] Long-term cost and efficacy analysis of latanoprost versus timolol in glaucoma patients in Germany
    Thelen, Ulrich
    Schnober, Dietmar
    Schoelzel, Sonja
    Kristoffersen, Michael S.
    Nelson, Lindsay A.
    Stewart, Jeanette A.
    Stewart, William C.
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2013, 6 (02) : 155 - 159
  • [23] Long-term cost and efficacy analysis of latanoprost versus timolol in glaucoma patients in Germany
    Ulrich Thelen
    Dietmar Schnober
    Sonja Schlzel
    Michael S.Kristoffersen
    Lindsay A.Nelson
    Jeanette A.Stewart
    William C.Stewart
    International Journal of Ophthalmology, 2013, (02) : 155 - 159
  • [24] Rate of response to latanoprost or timolol in patients with ocular hypertension or glaucoma
    Camras, CB
    Hedman, K
    JOURNAL OF GLAUCOMA, 2003, 12 (06) : 466 - 469
  • [25] Dorzolamide/timolol fixed combination versus latanoprost/timolol fixed combination in patients with primary open-angle glaucoma or ocular hypertension
    Cvenkel, Barbara
    Stewart, Jeanette A.
    Nelson, Lindsay A.
    Stewart, William C.
    CURRENT EYE RESEARCH, 2008, 33 (02) : 163 - 168
  • [26] A cost-effectiveness comparison of bimatoprost versus latanoprost in patients with glaucoma or ocular hypertension - Response
    Walt, J
    Lee, JR
    SURVEY OF OPHTHALMOLOGY, 2004, 49 (06) : 623 - 624
  • [27] A latanoprost cationic emulsion (STN1013001) vs. other latanoprost formulations (Latanoprost) in open angle glaucoma/ocular hypertension and ocular surface disease: an Italian cost-utility analysis
    Lazzaro, Carlo
    van Steen, Cecile
    Ghirelli, Giorgio
    Sacchi, Matteo
    Sisto, Dario
    Uva, Maurizio
    Varano, Luigi
    Angelillo, Luigi
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2023, 23 (02) : 251 - 265
  • [28] CONJUNCTIVAL HYPERAEMIA ASSOCIATED WITH THE FIXED COMBINATIONS OF LATANOPROST/TIMOLOL AND BIMATOPROST/TIMOLOL IN THE TREATMENT OF OCULAR HYPERTENSION OR GLAUCOMA
    Vinuesa, M. J.
    Vinuesa, I
    Diaz, S.
    Martin, I
    Soto, J.
    Fernandez-Arias, I
    VALUE IN HEALTH, 2009, 12 (07) : A453 - A453
  • [29] Efficacy and safety of latanoprost versus travoprost in exfoliative glaucoma patients
    Konstas, Anastasios G. P.
    Kozobolis, Vassilios P.
    Katsimpris, Ioannis E.
    Boboridis, Kostantinos
    Koukoula, Stavrenia
    Jenkins, Jessica N.
    Stewart, William C.
    OPHTHALMOLOGY, 2007, 114 (04) : 653 - 657
  • [30] A cost-utility analysis of losartan versus atenolol in the treatment of hypertension with left ventricular hypertrophy
    Anis, AH
    Sun, HY
    Singh, S
    Woolcott, J
    Nosyk, B
    Brisson, M
    PHARMACOECONOMICS, 2006, 24 (04) : 387 - 400
12345